argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
15 mar 2023 - 14:47
Statutory name
argenx SE
Title
argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis
Date last update: 27 October 2026